The Prague Post - US court keeps abortion drug available -- for now

EUR -
AED 4.299797
AFN 74.931614
ALL 96.031574
AMD 440.479809
AOA 1073.632019
ARS 1630.923879
AUD 1.658735
AWG 2.110384
AZN 1.991069
BAM 1.957572
BBD 2.356632
BDT 143.793374
BHD 0.441991
BIF 3477.543108
BMD 1.17081
BND 1.491605
BOB 8.084868
BRL 5.951814
BSD 1.170009
BTN 108.01968
BWP 15.698335
BYN 3.415189
BYR 22947.867085
BZD 2.353219
CAD 1.622572
CDF 2692.862132
CHF 0.922241
CLF 0.026918
CLP 1062.884195
CNY 8.028711
CNH 7.989575
COP 4321.376075
CRC 544.269303
CUC 1.17081
CUP 31.026453
CVE 110.364877
CZK 24.380949
DJF 208.360551
DKK 7.472634
DOP 70.751913
DZD 154.895116
EGP 62.392677
ERN 17.562143
ETB 182.71729
FJD 2.590357
FKP 0.884233
GBP 0.868934
GEL 3.137852
GGP 0.884233
GHS 12.881943
GIP 0.884233
GMD 86.055927
GNF 10266.290664
GTQ 8.9511
GYD 244.79212
HKD 9.170184
HNL 31.075122
HRK 7.538722
HTG 153.391609
HUF 375.716879
IDR 19879.175267
ILS 3.601691
IMP 0.884233
INR 108.120574
IQD 1532.787123
IRR 1540639.010301
ISK 143.799546
JEP 0.884233
JMD 184.186683
JOD 0.830104
JPY 185.184012
KES 151.490849
KGS 102.387268
KHR 4687.98221
KMF 499.935712
KPW 1053.715591
KRW 1726.657212
KWD 0.361886
KYD 0.975028
KZT 559.409525
LAK 25810.034579
LBP 104795.918983
LKR 368.813765
LRD 215.285633
LSL 19.207782
LTL 3.457096
LVL 0.708211
LYD 7.42572
MAD 10.885551
MDL 20.148115
MGA 4861.150068
MKD 61.686862
MMK 2458.707556
MNT 4181.642855
MOP 9.439759
MRU 46.500081
MUR 54.747097
MVR 18.089
MWK 2028.840729
MXN 20.374509
MYR 4.655158
MZN 74.873654
NAD 19.207782
NGN 1611.209698
NIO 43.057679
NOK 11.152207
NPR 172.834243
NZD 2.00562
OMR 0.450179
PAB 1.169999
PEN 4.008608
PGK 5.137649
PHP 69.525596
PKR 326.427607
PLN 4.253036
PYG 7589.868588
QAR 4.266561
RON 5.094543
RSD 117.344404
RUB 92.024048
RWF 1712.955071
SAR 4.39342
SBD 9.423358
SCR 16.267549
SDG 703.656832
SEK 10.78531
SGD 1.490218
SLE 28.805163
SOS 668.685149
SRD 43.838662
STD 24233.39373
STN 24.521144
SVC 10.238265
SYP 129.432241
SZL 19.203476
THB 37.319602
TJS 11.121242
TMT 4.109542
TND 3.416892
TRY 52.087256
TTD 7.935843
TWD 37.133975
TZS 3047.034824
UAH 50.705169
UGX 4328.714002
USD 1.17081
UYU 47.533016
UZS 14309.950047
VES 554.33992
VND 30830.342348
VUV 139.819173
WST 3.244211
XAF 656.514677
XAG 0.015136
XAU 0.000244
XCD 3.164171
XCG 2.108745
XDR 0.818368
XOF 656.551158
XPF 119.331742
YER 279.296731
ZAR 19.094782
ZMK 10538.709692
ZMW 22.377104
ZWL 377.000196
  • RBGPF

    -13.5000

    69

    -19.57%

  • CMSC

    -0.0400

    22.14

    -0.18%

  • RYCEF

    -0.5000

    15.25

    -3.28%

  • JRI

    -0.0400

    12.69

    -0.32%

  • RIO

    0.6500

    94.66

    +0.69%

  • GSK

    -0.5300

    55.84

    -0.95%

  • CMSD

    -0.0600

    22.29

    -0.27%

  • BCE

    -0.4300

    23.83

    -1.8%

  • BCC

    0.9600

    74.71

    +1.28%

  • RELX

    -0.2500

    33.36

    -0.75%

  • NGG

    0.4600

    87.52

    +0.53%

  • VOD

    0.1700

    15.31

    +1.11%

  • BTI

    0.0900

    58.8

    +0.15%

  • AZN

    -2.0200

    200.81

    -1.01%

  • BP

    -0.2400

    47.24

    -0.51%

US court keeps abortion drug available -- for now
US court keeps abortion drug available -- for now / Photo: Robyn Beck - AFP/File

US court keeps abortion drug available -- for now

A US appeals court has blocked moves to ban a widely-used abortion pill -- but imposed tough restrictions on access, in the latest round of an intensifying battle over reproductive rights.

Text size:

The ruling issued late Wednesday preserves access for now to mifepristone -- used for more than half of all abortions in the United States -- but a question mark remains over its long-term availability in a case likely to go all the way to Supreme Court.

The new order limits access to women in the first seven weeks of pregnancy, down from 10; it requires in-person visits to obtain the pill -- a requirement lifted in recent years; and it blocks the medication from being sent by mail.

Wednesday's 2-1 ruling by a federal appeals court in New Orleans, Louisiana, came after a Texas judge overturned the Food and Drug Administration's (FDA) two-decades old approval of the drug last Friday.

The appellate court said its ruling would hold until the case was heard in full -- likely by the Supreme Court.

The latest standoff over women's reproductive freedom in America comes almost a year after the conservative-dominated Supreme Court overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.

- 'Commitment to women' -

US President Joe Biden has branded the Texas ruling as "out of bounds," and his spokeswoman, Karine Jean-Pierre, said Thursday the administration would continue fighting it in court.

"We believe that the law is on our side, and we will prevail," she told reporters during the president's visit to Dublin, Ireland.

"I can reassure the American people that that is our commitment to women ... to make sure that women are able to make decisions for themselves about their own body," she added.

Democrats and activists warn the Texas ruling -- issued by a judge appointed by former Republican president Donald Trump -- moves the nation one step closer to a nationwide abortion ban sought by many conservatives.

Judge Matthew Kacsmaryk's ruling came after a coalition of anti-abortion groups sued to freeze the national distribution of mifepristone.

The Texas judge, in his decision, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."

Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.

But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.

Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access the procedure -- or ban it outright.

The two New Orleans judges who voted to tighten restrictions on access, Kurt Engelhardt and Andrew Oldham, were also both appointed by Trump.

The third, Catharina Haynes, is an appointee of former president George W. Bush.

Shortly after the initial Texas decision, a judge in Washington state ruled in a separate case that access to mifepristone must be preserved. The dueling opinions, along with the appeals, mean the issue is almost certain to end up before the Supreme Court.

V.Nemec--TPP